Health Condition 1: F439- Reaction to severe stress, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Individuals between the age group of 21 to 60 years of both male and female suffering from anidra of minimum one month duration and occurs atleast 3 nights per week will be selected randomly for the study. Patients suffering from disturbed sleep having AIS Score Greater than 6 assessed on Athens insomnia scale. Patient or their parents willing to participate in the trial. Patient having symptoms of Anidra as mentioned in classical texts as well as presenting the complaints of reduction in sleep time, difficulty in initiating or maintaining sleep, Wakefulness during normal sleep, suffering from non-restorative sleep. Patients will be selected irrespective of sex, occupation, caste, religion, etc. who will agree to stop their previous medication.
Exclusion criteria
Exclusion criteria: 1.Patients below 21 years and above 60 years of age. 2. Pregnant lady and lactating mother. 3. Nidranasha due to Abhighata- are excluded because, it is a condition where the pain dominates to induce sleep disturbances. 4. Patient with other systemic disorders, breathing related disorders,hyperthyroidism and major psychiatric illness like schizophrenia,depressive psychosis, epilepsy etc. will not be registered. 5. Patients with alcohol dependency or drug dependency will be excluded from the study. 6. Patients having chronic illness like asthma, malignancies, liver cirrhosis, chronic renal failure, uncontrolled diabetes, Chronic obstructive Pulmonary Disorders and Hypertension etc. will be excluded. 7. Patients with acute illness like CardioVascular Accident, Congestive Cardiac Failure, Myocardial Infarction, acute pain conditions or any Grave disease will be excluded. 8. Patient not willing for consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effectiveness of trial drug Lakshadi Tail Shirodhara will be administered in the condition of Anidra for 15 days and efficacy of the drug will be observed and assessed related datas will be collected and analyse and result will be prepared accordinglyTimepoint: 15th Day,30th Day,45th Day,60th Day and 30 days after the trial is completed. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
P.G. Department of Samhita and Siddhant, State Ayurvedic College and Hospital, Lucknow